Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size

Overview

Journal Dermatol Ther (Heidelb)

Date 2022 Jun 25

PMID 35751738

Authors

Xue Gong

Tong Qiu

Liwei Feng

Kaiying Yang

Shiyi Dai

Jiangyuan Zhou

Xuepeng Zhang

Siyuan Chen

Yi Ji

Affiliations

Soon will be listed here.

Abstract

Introduction: Infantile hemangioma (IH) is the most common benign tumor in infancy, but information about its pathogenesis is limited. The aim of this study was to determine maternal and perinatal risk factors for IH.

Methods: A total of 1033 IH patients were enrolled in the study between 2017 and 2020. IH patients were matched with controls by sex. Trained investigators collected detailed information from the participants. Logistic regression models were used for multivariate analysis.

Results: The statistical analysis demonstrated that miscarriage history (odds ratio [OR] = 4.275; 95% confidence interval [CI] [3.195, 5.720]), anemia in pregnancy (OR = 4.228; 95% CI [3.083, 5.799]), preterm premature rupture of membranes (PPROM) (OR = 3.182; 95% CI [1.359, 7.454]), placenta previa (OR = 2.440; 95% CI [1.787, 3.333]), threatened miscarriage (OR = 2.290; 95% CI [1.726, 3.039]), premature rupture of membranes (PROM) (OR = 1.785; P < 0.05), progesterone use (OR = 1.614; P < 0.001) and abnormal amniotic fluid volume (OR = 1.499; P < 0.05) were independent risk factors for IH. Gestational diabetes mellitus (GDM) (OR = 0.607; 95% CI [0.464, 0.794]), multiple gestations (OR = 0.407; 95% CI [0.232, 0.713]), hypothyroidism (OR = 0.407; 95% CI [0.227, 0.730]) and uterine fibroids (OR = 0.393; 95% CI [0.250, 0.618]) may reduce the risk of IH.

Conclusions: Maternal and perinatal factors are closely associated with IH occurrence. Our study provides reliable clues to guide further exploration of the pathogenesis of IH.

Trial Registration: ClinicalTrials.gov, NCT03331744. Infantile hemangioma is the most common benign tumor in children, which seriously affects appearance and function and even threatens life. The pathogenesis is not clear, a detailed case-control study of the maternal and perinatal periods with a large sample size will facilitate the development of individualized and precise treatment, early and timely interventions for high-risk children and improvement of prognosis. Our study found that miscarriage history, anemia in pregnancy, preterm premature rupture of membranes (PPROM), placenta previa, threatened miscarriage, premature rupture of membranes (PROM), progesterone use and abnormal amniotic fluid volume were independent risk factors for IH.

Citing Articles

The Evaluation, Diagnosis, and Management of Infantile Hemangiomas-A Comprehensive Review.

Resic A, Barcot Z, Habek D, Pogorelic Z, Baskovic M J Clin Med. 2025; 14(2).

PMID: 39860430 PMC: 11765582. DOI: 10.3390/jcm14020425.

Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review.

Bellinato F, Marocchi M, Pecoraro L, Zaffanello M, Del Giglio M, Girolomoni G Children (Basel). 2024; 11(11).

PMID: 39594972 PMC: 11593309. DOI: 10.3390/children11111397.

Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway.

Li Y, Kong M, Qiu T, Ji Y Precis Clin Med. 2024; 7(4):pbae026.

PMID: 39507292 PMC: 11540160. DOI: 10.1093/pcmedi/pbae026.

Clinical characteristics and risk factors for acute abdomen in patients with abdominal lymphatic malformations.

Yang C, Qiu T, Yang M, Zhou J, Gong X, Yang K J Vasc Surg Venous Lymphat Disord. 2024; 13(1):101969.

PMID: 39305949 PMC: 11764771. DOI: 10.1016/j.jvsv.2024.101969.

Infantile hemangiomas: a dermatologist's perspective.

Sharma A, Gupta M, Mahajan R Eur J Pediatr. 2024; 183(10):4159-4168.

PMID: 39052139 DOI: 10.1007/s00431-024-05655-8.

References

Kanada K, Merin M, Munden A, Friedlander S . A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012; 161(2):240-5. DOI: 10.1016/j.jpeds.2012.02.052. View

Munden A, Butschek R, Tom W, Marshall J, Poeltler D, Krohne S . Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014; 170(4):907-13. PMC: 4410180. DOI: 10.1111/bjd.12804. View

Hunjan M, Schoch J, Anderson K, Lohse C, Marnach M, Hand J . Prenatal Risk Factors for Infantile Hemangioma Development. J Invest Dermatol. 2016; 137(4):954-957. PMC: 6309253. DOI: 10.1016/j.jid.2016.10.047. View

Grimmer J, Williams M, Pimentel R, Mineau G, Wood G, Bayrak-Toydemir P . Familial clustering of hemangiomas. Arch Otolaryngol Head Neck Surg. 2011; 137(8):757-60. DOI: 10.1001/archoto.2011.91. View

Greco M, Frieden I, Drolet B, Garzon M, Mancini A, Chamlin S . Infantile Hemangiomas in Twins: A Prospective Cohort Study. Pediatr Dermatol. 2016; 33(2):178-83. DOI: 10.1111/pde.12781. View

Baselga E, Roe E, Coulie J, Munoz F, Boon L, McCuaig C . Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy. JAMA Dermatol. 2016; 152(11):1239-1243. DOI: 10.1001/jamadermatol.2016.2905. View

Anderson K, Schoch J, Lohse C, Hand J, Davis D, Tollefson M . Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol. 2015; 74(1):120-6. PMC: 4994883. DOI: 10.1016/j.jaad.2015.08.024. View

Dickison P, Christou E, Wargon O . A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol. 2011; 28(6):663-669. DOI: 10.1111/j.1525-1470.2011.01568.x. View

Castren E, Salminen P, Gissler M, Stefanovic V, Pitkaranta A, Klockars T . Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration. Acta Paediatr. 2016; 105(8):940-5. DOI: 10.1111/apa.13460. View

10.

Auger N, Fraser W, Arbour L, Healy-Profitos J, Drolet B . Pre-eclampsia and risk of infantile haemangioma. Br J Dermatol. 2016; 176(2):371-377. DOI: 10.1111/bjd.14958. View

11.

Chen X, Ma G, Chen H, Ye X, Jin Y, Lin X . Maternal and perinatal risk factors for infantile hemangioma: a case-control study. Pediatr Dermatol. 2013; 30(4):457-61. DOI: 10.1111/pde.12042. View

12.

Li J, Chen X, Zhao S, Hu X, Chen C, Ouyang F . Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study. Arch Dermatol. 2011; 147(9):1049-56. DOI: 10.1001/archdermatol.2011.122. View

13.

Haggstrom A, Drolet B, Baselga E, Chamlin S, Garzon M, Horii K . Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007; 150(3):291-4. DOI: 10.1016/j.jpeds.2006.12.003. View

14.

de Jong S, Itinteang T, Withers A, Davis P, Tan S . Does hypoxia play a role in infantile hemangioma?. Arch Dermatol Res. 2016; 308(4):219-27. DOI: 10.1007/s00403-016-1635-x. View

15.

Tirpe A, Gulei D, Ciortea S, Crivii C, Berindan-Neagoe I . Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. Int J Mol Sci. 2019; 20(24). PMC: 6941045. DOI: 10.3390/ijms20246140. View

16.

Wilson W, Hay M . Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011; 11(6):393-410. DOI: 10.1038/nrc3064. View

17.

McKeown S . Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014; 87(1035):20130676. PMC: 4064601. DOI: 10.1259/bjr.20130676. View

18.

de Sa S, Willner E, Duraes Pereira T, Souza V, Boaventura G, de Azeredo V . ANEMIA IN PREGNANCY: IMPACT ON WEIGHT AND IN THE DEVELOPMENT OF ANEMIA IN NEWBORN. Nutr Hosp. 2015; 32(5):2071-9. DOI: 10.3305/nh.2015.32.5.9186. View

19.

Steer P . Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy. Obstet Gynecol. 2020; 135(3):731. DOI: 10.1097/AOG.0000000000003737. View

20.

Levy A, Fraser D, Katz M, Mazor M, Sheiner E . Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2005; 122(2):182-6. DOI: 10.1016/j.ejogrb.2005.02.015. View